These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16611899)

  • 1. The Us9 gene of bovine herpesvirus 1 (BHV-1) effectively complements a Us9-null strain of BHV-5 for anterograde transport, neurovirulence, and neuroinvasiveness in a rabbit model.
    Chowdhury SI; Mahmood S; Simon J; Al-Mubarak A; Zhou Y
    J Virol; 2006 May; 80(9):4396-405. PubMed ID: 16611899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine herpesvirus 5 (BHV-5) Us9 is essential for BHV-5 neuropathogenesis.
    Chowdhury SI; Onderci M; Bhattacharjee PS; Al-Mubarak A; Weiss ML; Zhou Y
    J Virol; 2002 Apr; 76(8):3839-51. PubMed ID: 11907224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurovirulence of glycoprotein C(gC)-deleted bovine herpesvirus type-5 (BHV-5) and BHV-5 expressing BHV-1 gC in a rabbit seizure model.
    Chowdhury SI; Lee BJ; Onderci M; Weiss ML; Mosier D
    J Neurovirol; 2000 Aug; 6(4):284-95. PubMed ID: 10951552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bovine herpesvirus type 1 envelope protein Us9 acidic domain is crucial for anterograde axonal transport.
    Chowdhury SI; Brum MC; Coats C; Doster A; Wei H; Jones C
    Vet Microbiol; 2011 Sep; 152(3-4):270-9. PubMed ID: 21640524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glycine-rich bovine herpesvirus 5 (BHV-5) gE-specific epitope within the ectodomain is important for BHV-5 neurovirulence.
    Al-Mubarak A; Zhou Y; Chowdhury SI
    J Virol; 2004 May; 78(9):4806-16. PubMed ID: 15078962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In the absence of glycoprotein I (gI), gE determines bovine herpesvirus type 5 neuroinvasiveness and neurovirulence.
    Al-Mubarak A; Chowdhury SI
    J Neurovirol; 2004 Aug; 10(4):233-43. PubMed ID: 15371153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine herpesvirus 5 glycoprotein E is important for neuroinvasiveness and neurovirulence in the olfactory pathway of the rabbit.
    Chowdhury SI; Lee BJ; Ozkul A; Weiss ML
    J Virol; 2000 Mar; 74(5):2094-106. PubMed ID: 10666239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein E (gE) specified by bovine herpesvirus type 5 (BHV-5) enables trans-neuronal virus spread and neurovirulence without being a structural component of enveloped virions.
    Al-Mubarak A; Simon J; Coats C; Okemba JD; Burton MD; Chowdhury SI
    Virology; 2007 Sep; 365(2):398-409. PubMed ID: 17477950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both viral and host factors contribute to neurovirulence of bovine herpesviruses 1 and 5 in interferon receptor-deficient mice.
    Abril C; Engels M; Liman A; Hilbe M; Albini S; Franchini M; Suter M; Ackermann M
    J Virol; 2004 Apr; 78(7):3644-53. PubMed ID: 15016885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bovine herpesvirus type 1 mutant virus with truncated glycoprotein E cytoplasmic tail has defective anterograde neuronal transport in rabbit dorsal root ganglia primary neuronal cultures in a microfluidic chamber system.
    Chowdhury SI; Coats J; Neis RA; Navarro SM; Paulsen DB; Feng JM
    J Neurovirol; 2010 Nov; 16(6):457-65. PubMed ID: 21080783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Envelope protein Us9 is required for the anterograde transport of bovine herpesvirus type 1 from trigeminal ganglia to nose and eye upon reactivation.
    Butchi NB; Jones C; Perez S; Doster A; Chowdhury SI
    J Neurovirol; 2007 Aug; 13(4):384-8. PubMed ID: 17849322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bovine herpesvirus type 1 mutant virus specifying a carboxyl-terminal truncation of glycoprotein E is defective in anterograde neuronal transport in rabbits and calves.
    Liu ZF; Brum MC; Doster A; Jones C; Chowdhury SI
    J Virol; 2008 Aug; 82(15):7432-42. PubMed ID: 18480434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the pseudorabies virus Us9 protein with homologs from other veterinary and human alphaherpesviruses.
    Lyman MG; Kemp CD; Taylor MP; Enquist LW
    J Virol; 2009 Jul; 83(14):6978-86. PubMed ID: 19420087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental infection of calves with a gI, gE, US9 negative bovine herpesvirus type 5.
    Hübner SO; Oliveira AP; Franco AC; Esteves PA; Silva AD; Spilki FR; Rijsewijk FA; Roehe PM
    Comp Immunol Microbiol Infect Dis; 2005 May; 28(3):187-96. PubMed ID: 15857658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathology of bovine herpesvirus type 5 (BHV-5) meningo-encephalitis in a rabbit seizure model.
    Chowdhury SI; Lee BJ; Mosier D; Sur JH; Osorio FA; Kennedy G; Weiss ML
    J Comp Pathol; 1997 Nov; 117(4):295-310. PubMed ID: 9502267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spread of bovine herpesvirus type 5 (BHV-5) in the rabbit brain after intranasal inoculation.
    Lee BJ; Weiss ML; Mosier D; Chowdhury SI
    J Neurovirol; 1999 Oct; 5(5):474-84. PubMed ID: 10568884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of an alphaherpesvirus membrane protein that is essential for anterograde axonal spread of infection in neurons.
    Taylor MP; Kramer T; Lyman MG; Kratchmarov R; Enquist LW
    mBio; 2012; 3(2):. PubMed ID: 22448044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine Herpesvirus 1 U
    Pannhorst K; Wei H; Yezid H; He J; Chowdhury SI
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine herpesvirus-5 infection in a rabbit experimental model: immunohistochemical study of the cellular response in the CNS.
    Machado GF; Bernardi F; Hosomi FY; Peiró JR; Weiblen R; Roehe PM; Alessi AC; Melo GD; Ramos AT; Maiorka PC
    Microb Pathog; 2013 Apr; 57():10-6. PubMed ID: 23375887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.